ATE221525T1 - Dithiolan derivate, deren herstellung und deren heileffekt - Google Patents

Dithiolan derivate, deren herstellung und deren heileffekt

Info

Publication number
ATE221525T1
ATE221525T1 AT98302532T AT98302532T ATE221525T1 AT E221525 T1 ATE221525 T1 AT E221525T1 AT 98302532 T AT98302532 T AT 98302532T AT 98302532 T AT98302532 T AT 98302532T AT E221525 T1 ATE221525 T1 AT E221525T1
Authority
AT
Austria
Prior art keywords
production
healing effects
dithiolane derivatives
dithiolane
derivatives
Prior art date
Application number
AT98302532T
Other languages
English (en)
Inventor
Takashi Fujita
Tomihisa Yokoyama
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE221525T1 publication Critical patent/ATE221525T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT98302532T 1997-04-02 1998-04-01 Dithiolan derivate, deren herstellung und deren heileffekt ATE221525T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8374997 1997-04-02
JP883798 1998-01-20

Publications (1)

Publication Number Publication Date
ATE221525T1 true ATE221525T1 (de) 2002-08-15

Family

ID=26343433

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98302532T ATE221525T1 (de) 1997-04-02 1998-04-01 Dithiolan derivate, deren herstellung und deren heileffekt

Country Status (23)

Country Link
US (2) US6013663A (de)
EP (2) EP1070710A3 (de)
KR (1) KR19980081044A (de)
CN (1) CN1208035A (de)
AR (1) AR012315A1 (de)
AT (1) ATE221525T1 (de)
AU (1) AU728488B2 (de)
BR (1) BR9806413A (de)
CA (1) CA2233682A1 (de)
CZ (1) CZ96798A3 (de)
DE (1) DE69806831T2 (de)
DK (1) DK0869126T3 (de)
ES (1) ES2179427T3 (de)
HU (1) HUP9800743A3 (de)
ID (1) ID19824A (de)
IL (1) IL123887A0 (de)
NO (1) NO981469L (de)
NZ (1) NZ330092A (de)
PL (1) PL325691A1 (de)
PT (1) PT869126E (de)
RU (2) RU2165932C2 (de)
TR (2) TR199800602A3 (de)
TW (1) TW508354B (de)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
WO2000007582A2 (en) * 1998-08-06 2000-02-17 Warner-Lambert Company Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
ATE277034T1 (de) * 1998-10-26 2004-10-15 Univ New York State Res Found Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
ATE276241T1 (de) 1998-11-25 2004-10-15 Yissum Res Dev Co Antioxidationsmittel
FR2787109B1 (fr) * 1998-12-15 2001-01-19 Adir Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
FR2805537A1 (fr) * 2000-02-24 2001-08-31 Sod Conseils Rech Applic Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2791677B1 (fr) * 1999-04-02 2001-08-17 Sod Conseils Rech Applic Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AR042572A1 (es) * 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
IT1312569B1 (it) * 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
GB9913226D0 (en) * 1999-06-07 1999-08-04 Novartis Ag Organic compounds
DE19941217A1 (de) * 1999-08-30 2001-03-15 Asta Medica Ag Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
AU7995300A (en) * 1999-10-05 2001-05-10 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
FR2806409B1 (fr) * 2000-03-16 2002-04-19 Sod Conseils Rech Applic Nouveaux derives heterocycliques de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
RU2260005C2 (ru) * 2000-03-16 2005-09-10 Сосьете Де Консей Де Решерш Э Д'Аппликасьон Сьентифик (С.К.Р.А.С.) Производные липоевой кислоты, способ их получения (варианты) и фармацевтическая композиция
US6387945B2 (en) * 2000-04-11 2002-05-14 The Regents Of The University Of California Lipoic acid analogs
EP1172110A3 (de) * 2000-07-07 2003-09-17 Basf Aktiengesellschaft Verwendung von Liponsäure zur Verbesserung der Bioverfügbarkeit von Mineralsalzen
US8697109B2 (en) 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US8647612B2 (en) * 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
US7914815B2 (en) * 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US8147816B2 (en) * 2000-08-16 2012-04-03 Encore Health, Llc Presbyopia treatment by lens alteration
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
US7935332B2 (en) * 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
US20050112113A1 (en) * 2000-08-16 2005-05-26 Till Jonathan S. Presbyopia treatment by lens alteration
IT1319195B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Processo per la produzione dell'acido r(+)alfa-lipoico.
IT1319196B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Sintesi dell'acido r(+)alfa-lipoico.
DE10201464B4 (de) * 2002-01-16 2005-06-16 Viatris Gmbh & Co. Kg Verfahren zur Herstellung reiner Thioctsäure
EP1476440A4 (de) * 2002-02-22 2005-06-01 Albany College Of Pharmacy Verfahren und verbindungen, die sich zur inhibierung von oxidativen schädigungen und/oder schädigungen durch freie radikale und zur behandlung und prävention von krankheiten eignen
AU2003208767A1 (en) * 2002-03-05 2003-09-16 Universitaet Ulm Dithiolane derivatives for immobilizing biomolecules on noble metals and semiconductors
JP3970811B2 (ja) 2002-09-09 2007-09-05 独立行政法人科学技術振興機構 リンカー化合物及びリガンド、並びにそれらの製造方法
US20040229815A1 (en) * 2003-01-03 2004-11-18 Nagasawa Herbert T. Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug
US7202270B2 (en) * 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
US7462526B2 (en) * 2003-11-18 2008-12-09 Silicon Genesis Corporation Method for fabricating semiconductor devices using strained silicon bearing material
US20080102119A1 (en) * 2006-11-01 2008-05-01 Medtronic, Inc. Osmotic pump apparatus and associated methods
US7389347B2 (en) * 2004-04-16 2008-06-17 International Business Machines Corporation Active probing for real-time diagnosis
WO2006080043A2 (en) * 2005-01-27 2006-08-03 Alma Mater Studiorum- Universita' Di Bologna Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
RU2292201C1 (ru) * 2005-05-30 2007-01-27 Пятигорская государственная фармацевтическая академия Композиция - мягкая лекарственная форма противоартрозного действия, содержащая диклофенак и глюкозамина гидрохлорид для ректального применения
JP2009507003A (ja) * 2005-09-01 2009-02-19 アレス トレーディング ソシエテ アノニム 視神経炎の治療
CN100436444C (zh) * 2006-07-29 2008-11-26 常熟富士莱医药化工有限公司 硫辛酰胺合成工艺
US9239329B2 (en) 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
WO2008106640A1 (en) * 2007-03-01 2008-09-04 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
WO2009014343A2 (en) * 2007-07-20 2009-01-29 Biogenics, Inc. Ascorbic acid derivatives having alpha-lipoyl groups and process for preparing the same
KR101056039B1 (ko) * 2007-07-20 2011-08-10 (주)바이오제닉스 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법
KR101056037B1 (ko) * 2007-07-20 2011-08-10 (주)바이오제닉스 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법
DE102007038849A1 (de) 2007-08-16 2009-02-19 Adscil Gmbh Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie
US8102027B2 (en) * 2007-08-21 2012-01-24 Broadcom Corporation IC package sacrificial structures for crack propagation confinement
WO2009086547A1 (en) * 2008-01-03 2009-07-09 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
CN101497600B (zh) * 2008-01-29 2012-02-08 首都医科大学 2,4,5-三取代-1,3-二硫戊环、其合成方法、其应用
US9044439B2 (en) 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
WO2009111635A2 (en) 2008-03-05 2009-09-11 Encore Health, Llc Dithiol compounds, derivatives, and uses therefor
EP2291182A1 (de) * 2008-05-13 2011-03-09 Genmedica Therapeutics SL Salicylat-konjugate zur behandlung von stoffwechselerkrankungen
EP2300451A1 (de) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Prodrugs nichtsteroider entzündungshemmender mittel mit einer grösse im nanometerbereich
FR2936146B1 (fr) 2008-09-24 2010-10-08 Oreal Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant.
FR2936153B1 (fr) * 2008-09-24 2010-10-08 Oreal Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant.
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
FR2937035B1 (fr) * 2008-10-10 2010-12-31 Oreal Composes dithiolanes ; compositions les contenant ; utilisations pour la photoprotection de la peau
EP2370435B1 (de) 2008-11-24 2015-01-07 Cedars-Sinai Medical Center Antioxidative camptothecinderivate und antioxidative antineoplastische nanospheren davon
FR2939042B1 (fr) * 2008-11-28 2010-11-26 Oreal PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES.
CN101787013B (zh) * 2009-01-22 2013-04-24 杭州民生药业有限公司 硫辛酰胺系列衍生物、制备方法及所述衍生物的制药用途
CA2755069A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
CN102421424A (zh) * 2009-03-16 2012-04-18 根梅迪卡治疗公司 用于治疗代谢性疾病的组合疗法
US7928067B2 (en) * 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
EP2821405B1 (de) 2009-06-15 2016-04-13 Encore Health, LLC Cholinester zur Behandlung von Presbyopie und Katarakt.
EP3069612A3 (de) 2009-06-15 2016-10-19 Encore Health, LLC Dithiolverbindungen, derivate davon und verwendungen davon
FR2952300B1 (fr) * 2009-11-09 2012-05-11 Oreal Nouveaux colorants fluorescents a motif heterocyclique disulfure, composition de teinture les comprenant et procede de coloration des fibres keratiniques humaines a partir de ces colorants
DK2640423T3 (en) 2010-11-18 2017-10-02 Ischemix Llc LIPOYL COMPOUNDS AND THEIR USE IN TREATMENT OF ISchemic DAMAGE
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
CA2891261C (en) 2012-11-15 2023-04-04 Brandeis University Tethering cysteine residues using cyclic disulfides
EP3110800A1 (de) * 2014-02-27 2017-01-04 Consorzio Interuniversitario Nazionale Per La Scienza E La Tecnologia Dei Materiali (INSTM) Neuartige verbindungen mit anti-allodynischer und antihyperalgesicher aktivität
CA2941518A1 (en) 2014-03-03 2015-09-11 Encore Vision, Inc. Lipoic acid choline ester compositions and methods of use
WO2016126662A1 (en) * 2015-02-03 2016-08-11 Kardiatonos, Inc. Compounds for the prevention and treatment of vascular disease
CA2994298A1 (en) 2015-08-18 2017-02-23 Brandeis University Tethering cysteine residues using cyclic disulfides
EP4018997A1 (de) * 2016-03-14 2022-06-29 NeoStrata Company, Inc. N-lipon-aminosäure oder peptide, derivate und deren verwendungen
US12435056B2 (en) 2016-03-14 2025-10-07 Neostrata Company, Inc. N-lipoic-amino acid or peptide, derivatives and their uses
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN106866620B (zh) * 2017-03-30 2019-09-20 山东齐都药业有限公司 一种硫辛酸氧化杂质的制备方法
AU2018258158A1 (en) 2017-04-25 2019-11-21 Ischemix Llc Compositions and methods for treating traumatic brain injury
US20220151989A1 (en) * 2019-04-17 2022-05-19 Santen Pharmaceutical Co., Ltd. Lipoic acid prodrug
CN110294738A (zh) * 2019-07-22 2019-10-01 通化师范学院 硫辛酸衍生物及其制备方法和用途
KR102701383B1 (ko) * 2022-11-11 2024-09-04 주식회사 메디치바이오 리포-하이드록삼산 유도체 및 이의 약학적 용도
EP4616853A1 (de) * 2022-11-11 2025-09-17 Medicibio Co., Ltd Lipohydroxamsäurederivat und pharmazeutische verwendung davon
GB202305212D0 (en) * 2023-04-06 2023-05-24 Elixa Mediscience Ltd Compounds
US12152174B2 (en) * 2023-04-13 2024-11-26 The Regents Of The University Of California Adjustably stable adhesive compositions for medical and non-medical uses, and recycling
CN118652428B (zh) * 2024-08-12 2024-11-19 浙江明斯特新材料有限公司 紫外光固化材料、固化聚合物材料、其制备方法及应用
US12269925B1 (en) 2024-08-13 2025-04-08 The Regents Of The University Of California Fast curing, biocompatible and biodegradable adhesives and sealants

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210892B (de) * 1959-10-13 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 5[3-(1, 2-Dithiacylopentyl)]-pentan-saeureamiden
DE1210893B (de) * 1960-06-17 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 6, 8-Dithiooctansaeureamiden
FR1294134A (fr) * 1960-12-27 1962-05-26 Takeda Pharmaceutical Ind Procédé de préparation d'alpha-lipoamides
SU527432A1 (ru) * 1974-11-10 1976-09-05 Всесоюзный Научно-Исследовательский Витаминный Институт Способ получени амида липоевой кислоты
FR2541680B1 (fr) * 1983-02-24 1985-06-14 Rhone Poulenc Sante Nouveaux derives de l'amino-5 dithiole-1,2 one-3, leur preparation et les compositions medicinales qui les contiennent
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPH0673005B2 (ja) * 1985-01-24 1994-09-14 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
JPH0670133B2 (ja) * 1985-08-29 1994-09-07 出光興産株式会社 リポアミド膜およびその製造法
JP2553090B2 (ja) 1987-07-21 1996-11-13 帝人株式会社 組織グルタチオンレベル向上剤
DE3900649A1 (de) * 1989-01-11 1990-07-12 Boehringer Mannheim Gmbh Verfahren zur abloesung eines analyten von seinem bindeprotein
FR2653334B1 (fr) * 1989-10-19 1991-12-20 Erphar Ste Civile Preparation cosmetique de bronzage.
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
WO1993002076A1 (fr) * 1991-07-18 1993-02-04 Kyowa Hakko Kogyo Co., Ltd. Compose de 1,2-dithiolane
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
IT1256178B (it) 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
FR2707983A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés de l'acide lipoïque et dihydrolipoïque, leur préparation et leur application en thérapeutique humaine.
DE4327462A1 (de) * 1993-08-16 1995-02-23 Carl Heinrich Dr Weischer Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
DE4343593C2 (de) * 1993-12-21 1998-05-20 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz
AU1113097A (en) * 1995-12-14 1997-07-03 Mark Borisovich Balazovsky Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof

Also Published As

Publication number Publication date
RU99119545A (ru) 2004-03-27
EP0869126A1 (de) 1998-10-07
TW508354B (en) 2002-11-01
DE69806831D1 (de) 2002-09-05
AU5970298A (en) 1998-10-08
DK0869126T3 (da) 2002-11-18
DE69806831T2 (de) 2003-03-27
NZ330092A (en) 1999-04-29
IL123887A0 (en) 1998-10-30
HU9800743D0 (en) 1998-05-28
HK1015765A1 (en) 1999-10-22
CA2233682A1 (en) 1998-10-02
EP0869126B1 (de) 2002-07-31
EP1070710A2 (de) 2001-01-24
EP1070710A3 (de) 2001-03-21
PL325691A1 (en) 1998-10-12
CN1208035A (zh) 1999-02-17
HUP9800743A2 (hu) 2000-05-28
PT869126E (pt) 2002-10-31
TR200202678A2 (tr) 2004-01-21
AU728488B2 (en) 2001-01-11
US6013663A (en) 2000-01-11
NO981469L (no) 1998-10-05
NO981469D0 (no) 1998-04-01
TR199800602A2 (xx) 1999-10-21
US6313164B1 (en) 2001-11-06
RU2165932C2 (ru) 2001-04-27
CZ96798A3 (cs) 1998-10-14
AR012315A1 (es) 2000-10-18
KR19980081044A (ko) 1998-11-25
HUP9800743A3 (en) 2001-10-29
RU2169731C2 (ru) 2001-06-27
MX9802679A (es) 1998-12-31
ID19824A (id) 1998-08-06
BR9806413A (pt) 2003-04-15
ES2179427T3 (es) 2003-01-16
TR199800602A3 (tr) 1999-10-21

Similar Documents

Publication Publication Date Title
ATE221525T1 (de) Dithiolan derivate, deren herstellung und deren heileffekt
ATE188471T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69903464D1 (de) Haftverschlüsse, deren herstellung und sie aufweisenden produkten
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE59610557D1 (de) Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide
DE69623992D1 (de) Derivate von dolestatin, deren herstellung und verwendung
ATE237580T1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
DE69622148D1 (de) Chinazozin derivate und deren verwendung
DE69627411D1 (de) Triazinderivate, ihre Herstellung und Verwendung
DE69613368D1 (de) Chinazolin derivate
DE69613367D1 (de) Chinazolin derivate
DE69907698D1 (de) Azetidinderivate, deren herstellung und sie enthaltende arzneimittel
ATE258549T1 (de) Oxazolidindion-derivate, ihre herstellung und verwendung
ATE310003T1 (de) Benzodiazepin-derivate, deren herstellung und anwendung
DE69637405D1 (de) Pyridazin-3-on derivate, deren verwendung und zwischenprodukte für deren herstellung
ATE430734T1 (de) Isochinoline und deren herstellung
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
DE69625857D1 (de) Siliconderivate, ihre Herstellung und Verwendung
DE69903143D1 (de) Chromanon und thiochromanon derivate
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
PT1140835E (pt) Derivados da 3,3-biarilpiperidina e 2,2-biarilmorfolina
DE50002417D1 (de) 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE69809091D1 (de) Phenylphosphonsäurederivate und deren Herstellung
ITMI940506A0 (it) Derivati chinzolilamminici attivi come alfa-antagonisti

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee